“The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020029, Apr. 2020, doi: 10.4084/mjhid.2020.029.